Philippe Froguel Selected Research

Intergenic DNA (Junk DNA)

10/2020	Obesity status modifies the association between rs7556897T>C in the intergenic region SLC19A3-CCL20 and blood pressure in French children.
1/2017	Copy Number Variations in Candidate Genes and Intergenic Regions Affect Body Mass Index and Abdominal Obesity in Mexican Children.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Philippe Froguel Research Topics

Disease

102	Type 2 Diabetes Mellitus (MODY) 01/2022 - 01/2002
90	Obesity 01/2022 - 01/2002
67	Insulin Resistance 01/2022 - 02/2002
17	Inflammation (Inflammations) 01/2021 - 03/2007
13	Glucose Intolerance 01/2021 - 07/2002
12	Body Weight (Weight, Body) 01/2018 - 05/2002
9	Weight Loss (Weight Reduction) 08/2016 - 06/2006
8	Hyperglycemia 01/2022 - 04/2004
8	Morbid Obesity 01/2018 - 12/2003
6	Mason-Type Diabetes 10/2020 - 03/2003
6	Atherosclerosis 04/2014 - 07/2002
6	Metabolic Syndrome (Dysmetabolic Syndrome X) 08/2008 - 04/2003
5	Birth Weight (Birth Weights) 01/2019 - 04/2005
5	Diabetes Mellitus 11/2016 - 01/2007
4	Genetic Risk Score 01/2022 - 08/2014
4	Genetic Predisposition to Disease (Genetic Predisposition) 01/2021 - 11/2004
4	Metabolic Diseases (Metabolic Disease) 01/2020 - 04/2005
4	Infections 01/2018 - 09/2010
4	Hyperphagia (Overeating) 04/2014 - 11/2008
4	Pediatric Obesity 06/2008 - 01/2003
3	Dyslipidemias (Dyslipidemia) 01/2022 - 08/2004
3	Overweight 10/2020 - 04/2010
3	Cardiovascular Diseases (Cardiovascular Disease) 12/2018 - 05/2011
3	Coronary Disease (Coronary Heart Disease) 01/2017 - 07/2009
3	Neoplasms (Cancer) 01/2015 - 05/2011
3	Hypertension (High Blood Pressure) 11/2013 - 02/2007
2	Disease Progression 01/2022 - 09/2010
2	Weight Gain 01/2021 - 02/2006
2	Prediabetic State (Prediabetes) 01/2020 - 01/2019
2	Colorectal Neoplasms (Colorectal Cancer) 12/2018 - 07/2014
2	Autoimmune Diseases (Autoimmune Disease) 11/2018 - 05/2011
2	Hyperinsulinism (Hyperinsulinemia) 01/2018 - 10/2009
2	Hypoxia (Hypoxemia) 12/2016 - 07/2008

Drug/Important Bio-Agent (IBA)

70	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 05/2002
53	Insulin (Novolin)FDA Link 01/2022 - 08/2002
25	AdiponectinIBA 07/2012 - 02/2002
16	Proteins (Proteins, Gene)FDA Link 01/2017 - 01/2002
15	LipidsIBA 01/2021 - 01/2003
12	Biological ProductsIBA 01/2019 - 01/2002
12	Transcription Factors (Transcription Factor)IBA 04/2014 - 06/2006
11	Hormones (Hormone)IBA 04/2014 - 07/2002
10	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2015
10	LeptinIBA 01/2018 - 05/2002
9	EnzymesIBA 10/2015 - 12/2003
8	Type 4 Melanocortin Receptor (Melanocortin-4 Receptor)IBA 11/2019 - 01/2003
8	DNA (Deoxyribonucleic Acid)IBA 01/2018 - 12/2003
6	Melatonin Receptors (Melatonin Receptor)IBA 01/2020 - 11/2009
6	GlucokinaseIBA 02/2010 - 06/2006
5	MelanocortinsIBA 01/2022 - 11/2008
5	Pharmaceutical PreparationsIBA 01/2021 - 01/2002
5	Triglycerides (Triacylglycerol)IBA 05/2012 - 09/2006
5	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 04/2010 - 01/2003
4	Blood Glucose (Blood Sugar)IBA 01/2022 - 11/2009
4	LDL CholesterolIBA 01/2017 - 02/2007
4	AdipokinesIBA 12/2016 - 08/2003
4	KynurenineIBA 01/2016 - 07/2012
4	PPAR gammaIBA 07/2008 - 03/2005
3	ChromatinIBA 01/2021 - 12/2009
3	Messenger RNA (mRNA)IBA 10/2020 - 10/2006
3	CholesterolIBA 01/2020 - 01/2012
3	Hemoglobins (Hemoglobin)IBA 01/2019 - 11/2009
3	C-Reactive ProteinIBA 11/2018 - 07/2009
3	oxidized low density lipoproteinIBA 01/2016 - 02/2007
3	Tryptophan (L-Tryptophan)FDA Link 01/2016 - 07/2012
3	CytokinesIBA 10/2015 - 07/2012
3	Leptin ReceptorsIBA 01/2015 - 10/2006
3	Interleukin-6 (Interleukin 6)IBA 04/2010 - 08/2003
3	Apolipoproteins E (ApoE)IBA 07/2009 - 01/2003
3	GhrelinIBA 04/2009 - 08/2002
3	Fatty Acids (Saturated Fatty Acids)IBA 05/2007 - 01/2003
2	CalciumIBA 11/2022 - 04/2014
2	Hypoglycemic Agents (Hypoglycemics)IBA 01/2021 - 12/2003
2	Intergenic DNA (Junk DNA)IBA 10/2020 - 01/2017
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2020 - 01/2017
2	MT2 Melatonin ReceptorIBA 01/2020 - 01/2018
2	ORALIT (ORS)IBA 10/2019 - 10/2009
2	Insulin ReceptorIBA 01/2018 - 03/2006
2	MelatoninIBA 10/2017 - 01/2017
2	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 09/2017 - 10/2011
2	ChemokinesIBA 10/2016 - 12/2013
2	Mixed Function Oxygenases (Monooxygenases)IBA 01/2016 - 10/2015
2	Amylases FDA Link 02/2015 - 05/2014
2	ProinsulinIBA 06/2014 - 10/2011
2	Small Interfering RNA (siRNA)IBA 04/2014 - 12/2007
2	Glucagon (Glukagon)FDA Link 04/2014 - 05/2002
2	KATP ChannelsIBA 11/2013 - 01/2007
2	HDL CholesterolIBA 05/2012 - 07/2010
2	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 01/2012 - 03/2008
2	Glycoproteins (Glycoprotein)IBA 10/2011 - 08/2005
2	CarbohydratesIBA 10/2011 - 02/2010
2	Codon (Codons)IBA 02/2010 - 03/2008
2	Phosphatidylinositol 3-Kinases (PI 3 Kinase)IBA 10/2009 - 02/2008
2	Nicotinamide PhosphoribosyltransferaseIBA 08/2009 - 07/2008
2	EndocannabinoidsIBA 07/2008 - 01/2008

Therapy/Procedure

5	Precision Medicine 10/2020 - 12/2010
4	Therapeutics 01/2020 - 10/2010
4	Bariatric Surgery 08/2016 - 07/2013
3	Lasers (Laser) 01/2019 - 01/2013
2	Glycemic Control 09/2017 - 01/2011
2	Gastric Bypass (Roux-en-Y Gastric Bypass) 07/2014 - 07/2013